Colesevelam Hydrochloride contains Bile Acid Binding Capacity (HPLC): Glycocholate (GC) binding 0.800~1.400 mmol/g; Glycochenodeoxycholate (GCDC) binding 2.700~3.600 mmol/g; Taurodeoxycholic acid (TDC) binding 1.000~1.400 mmol/g; Total bile acid binding capacity 4.50~6.40 mmol/g

共有 1 個藥物證書使用此成份

"台耀"克攝萌
Colesevelam hydrochloride "F.L."

• 申請商: 台耀化學股份有限公司
• 適應症: 臨床上用來降低病人總膽固醇及低密度脂蛋白(LDL)之輔助療法。
• 發證日期: 2012-01-10